Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-05-12 Purchase | 2022-05-13 4:37 pm | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 10,000 | $12.15 | $121,526 | 428,326 (Indirect) | View |
2022-03-15 Purchase | 2022-03-17 07:58 am | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 4,000 | $21.38 | $85,535 | 418,326 (Indirect) | View |
2021-12-02 Purchase | 2021-12-06 08:11 am | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 4,700 | $31.34 | $147,304 | 414,326 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 136,139 | $0 | 136,139 (Direct) | View |
2022-11-07 Ownership | 2024-02-09 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 409,626 | $0 | 428,326 (Indirect) | View |
2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 26,642 | $0 | 26,642 (Direct) | View |
2022-06-09 Option Award | 2022-06-13 5:00 pm | N/A 2032-06-08 | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 15,500 | $0 | 15,500 (Direct) | View |
Ownership | 2021-06-16 7:33 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director 10% Owner | 0 | $0 | 452,824 (Indirect) | View |
2020-06-11 Option Award | 2020-06-12 11:44 am | N/A 2030-06-10 | CATABASIS PHARMACEUTICALS INC | CATB | ADELMAN BURT A Director | 7,500 | $0 | 7,500 (Direct) | View |